These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3617151)

  • 61. [Comparative study of a combination of amoxicillin and clavulanic acid and a combination of ticarcillin and clavulanic acid on 249 enterobacteria].
    Aubert G; Lallard P; Dorche G; Denis M
    Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):651-4. PubMed ID: 3054741
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Pharmacokinetics of azlocillin in chronic renal failure and hemodialysis patients].
    Fillastre JP; Humbert G; Leroy A; Godin M
    Presse Med; 1984 Mar; 13(13):797-801. PubMed ID: 6231597
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacokinetics of ticarcillin in man.
    Davies BE; Humphrey MJ; Langley PF; Lees L; Legg B; Wadds GA
    Eur J Clin Pharmacol; 1982; 23(2):167-72. PubMed ID: 7140806
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Pharmacokinetics of ticarcillin in the dog.
    Tilmant L; Brown MP; Gronwall RR
    Am J Vet Res; 1985 Feb; 46(2):479-81. PubMed ID: 3922261
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Clearance of ticarcillin-clavulanic acid by continuous venovenous hemofiltration in three critically ill children, two with and one without concomitant extracorporeal membrane oxygenation.
    Lindsay CA; Bawdon R; Quigley R
    Pharmacotherapy; 1996; 16(3):458-62. PubMed ID: 8726606
    [TBL] [Abstract][Full Text] [Related]  

  • 66. [Evaluation of the biliary excretion of a ticarcillin-clavulanic acid combination in man].
    Brogard JM; Blickle JF; Jehl F; Adloff M; Monteil H
    Pathol Biol (Paris); 1988 May; 36(5):500-6. PubMed ID: 3043347
    [TBL] [Abstract][Full Text] [Related]  

  • 67. [Effect of clavulanic acid/ticarcillin on severe infections accompanying hematological diseases].
    Urabe A; Takaku F; Kitagawa S; Miura Y; Dan K; Nomura T; Masuda M; Mizoguchi H; Yano T; Toyama K
    Jpn J Antibiot; 1987 Apr; 40(4):749-58. PubMed ID: 3613092
    [TBL] [Abstract][Full Text] [Related]  

  • 68. [Clinical evaluation of a ticarcillin-clavulanic acid combination in severe infections in adults].
    Lacut JY; Quentin C; Cardoso-Mendes I; Dupon M
    Pathol Biol (Paris); 1985 Jun; 33(5 Pt 2):591-5. PubMed ID: 3937132
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Comparative pharmacokinetics of low- and high-dose ticarcillin.
    Guglielmo BJ; Flaherty JF; Batman R; Barriere SL; Gambertoglio JG
    Antimicrob Agents Chemother; 1986 Sep; 30(3):359-60. PubMed ID: 3777901
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Biliary elimination of ticarcillin plus clavulanic acid (Claventin): experimental and clinical study.
    Brogard JM; Jehl F; Blickle JF; Adloff M; Dorner M; Montell H
    Int J Clin Pharmacol Ther Toxicol; 1989 Mar; 27(3):135-44. PubMed ID: 2722309
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Activity of penicillin or ticarcillin in combination with clavulanic acid in the treatment of experimental intra-abdominal abscess.
    Bansal MB; Prabahala R; Thadepalli H
    J Antimicrob Chemother; 1986 Feb; 17(2):221-6. PubMed ID: 3700288
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ticarcillin plus clavulanic acid versus cefoxitin in the prophylaxis of infection after cesarean section.
    Saltzman DH; Eron LJ; Toy C; Protomastro LJ; Sites JG
    Am J Med; 1985 Nov; 79(5B):172-3. PubMed ID: 3907340
    [No Abstract]   [Full Text] [Related]  

  • 73. Comparative study of ticarcillin plus clavulanate potassium and moxalactam in the treatment of surgical infections of the soft tissue.
    Timmes JJ
    Am J Med; 1985 Nov; 79(5B):134-5. PubMed ID: 4073080
    [No Abstract]   [Full Text] [Related]  

  • 74. Cerebrospinal fluid penetration after single or multiple dosage with ticarcillin/clavulanate.
    Franz P; von Rosen F; Garner C; Swozil U; Schmiedek P; Einhäupl K; Adam D
    J Antimicrob Chemother; 1989 Nov; 24 Suppl B():107-10. PubMed ID: 2606812
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Ticarcillin disodium plus clavulanate potassium as initial therapy for hospitalized pediatric patients.
    Blumer JL
    Am J Med; 1985 Nov; 79(5B):192-3. PubMed ID: 4073091
    [No Abstract]   [Full Text] [Related]  

  • 76. Effects of impaired renal function, hemodialysis, and peritoneal dialysis on the pharmacokinetics of mezlocillin.
    Kampf D; Schurig R; Weihermüller K; Förster D
    Antimicrob Agents Chemother; 1980 Jul; 18(1):81-7. PubMed ID: 6448024
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ticarcillin-clavulanic acid therapy in severe infections.
    Van der Auwera P; Legrand JC
    Drugs Exp Clin Res; 1985; 11(11):805-13. PubMed ID: 3836862
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Parenteral augmentin: pharmacokinetics.
    Staniforth DH; Jackson D; Horton R; Davies B
    Int J Clin Pharmacol Ther Toxicol; 1984 Aug; 22(8):430-4. PubMed ID: 6490225
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Timentin--clinical and pharmacokinetic evaluation in otorhinolaryngology.
    Federspil P; Koch A; Schätzle W; Tiesler E
    J Antimicrob Chemother; 1986 May; 17 Suppl C():103-13. PubMed ID: 3722042
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Ticarcillin-clavulanic acid dosing ratio for treatment of experimental Staphylococcus aureus endocarditis.
    Goodman JS
    Antimicrob Agents Chemother; 1992 Jul; 36(7):1585. PubMed ID: 1510459
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.